LWLin Wu

Lin Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lin Wu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Binxun Li

    Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute of Wuhan University, Wuhan, 430060, Hubei, People's Republic of China

    1 shared publication
  • Dongdong Zhao

    Tongji Univ, Shanghai Peoples Hosp 10, Dept Cardiol, Sch Med, 301 Yanchang Rd, Shanghai 200072, Peoples R China

    1 shared publication
  • Hong Jiang

    Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China

    1 shared publication
  • Hua Ye

    Department of Burns & Plastic and Wound Repair, Ganzhou People’s Hospital, Ganzhou, China

    1 shared publication
  • Jiajin Tu

    Department of Burns & Plastic and Wound Repair, Ganzhou People’s Hospital, Ganzhou, China

    1 shared publication
  • Runyang Feng

    Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital Fudan University, Shanghai, China

    1 shared publication

Latest Publications

  • Open Access

    Targeting DNA damage signaling in atherosclerosis: molecular mechanisms and therapeutic opportunities

    by Hua Ye, Yushan Li, Yiran E. Li, Runyang Feng, Yanmei Liu, Jiajin Tu, Lin Wu

  • Open Access

    Light-emitting diode therapy protects against ventricular arrhythmias by neuro-immune modulation in myocardial ischemia and reperfusion rat model

    by Songyun Wang, Lin Wu, Xuemeng Li, Binxun Li, Yi Zhai, Dongdong Zhao, Hong Jiang

    Sympathetic overactivation and inflammation are two major mediators to post-myocardial ischemia-reperfusion (I/R)-induced ventricular arrhythmia (VA). The vicious cycle between microglia and sympathetic activation plays an important role in sympathetic hyperactivity related to cardiovascular diseases. Recently, studies have shown that microglial activation might be attenuated by light-emitting diode (LED) therapy. Therefore, we hypothesized that LED therapy might protect against myocardial I/R-induced VAs by attenuating microglial and sympathetic activation. Thirty-six male anesthetized rats were randomized into four groups: control group (n = 6), LED group (n = 6), I/R group (n = 12), and LED+I/R group (n = 12). I/R was generated by left anterior descending artery occlusion for 30 min followed by 3 h reperfusion. ECG and left stellate ganglion (LSG) neural activity were recorded continuously. After 3 h reperfusion, a programmed stimulation protocol was conducted to test the inducibility of VA. Furthermore, we extracted the brain tissue to examine the microglial activation, and the peri-ischemic myocardium to examine the expression of NGF and inflammatory cytokines (IL-1β, IL-18, IL-6, and TNF-α). As compared to the I/R group, LED illumination significantly inhibited the LSG neural activity (P < 0.01) and reduced the inducibility of VAs (arrhythmia score 4.417 ± 0.358 vs. 3 ± 0.3257, P < 0.01) in the LED+I/R group. Furthermore, LED significantly attenuated microglial activation and downregulated the expression of inflammatory cytokines and NGF in the peri-infarct myocardium. LED therapy may protect against myocardial I/R-induced VAs by central and peripheral neuro-immune regulation.